| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.03 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.065 | 0.03 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.03 |